James Gulley, M.D.
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James Gulley, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:03 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04847050 · A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor TherapyNational Cancer Institute (NCI) · completed · Solid Tumor Malignancy, Hematologic Malignancy, Leukemia · principal investigator
- Ph2NCT04538378 · Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine TumorsNational Cancer Institute (NCI) · terminated · EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine · principal investigator
- Ph1/Ph2NCT04209595 · PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell CancersNational Cancer Institute (NCI) · completed · Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas · principal investigator
- Ph2NCT01838642 · Ponatinib for Advanced Medullary Thyroid CancerNational Institutes of Health Clinical Center (CC) · terminated · Thyroid Neoplasms · principal investigator
- Ph1/Ph2NCT01240590 · A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)National Cancer Institute (NCI) · completed · Solid Tumor, Anaplastic Thyroid Cancer · principal investigator
- Ph2NCT00007345 · Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell LymphomaNational Cancer Institute (NCI) · completed · Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 19 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.